Aimmune Therapeutics

AIMT

23.62

-0.28

-1.2%

After Hours:

23.62

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 23.85
Prev. Close: 23.90
Low/Hi: 23.30 - 23.95
52-Week: 14.11 - 27.31
Volumes
Equity: 240,843
90-Day Avg: 261,302
Option: 1,682
90-Day Avg: 49
Volatility
Todays Stock Vol: 25.0
20-Day (HV): 45.9
52-Week (HV): 50.8
30-Day IV: 107.3 +10.9
IV Pct Rank: 100% Elevated
Fundamental
Div. Yield: 0.0%
Earnings: 15-Nov (Est.)
P/E Ratio:
Market Cap: 1.2 B
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

AIMT Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Net Income -32,497 -25,870 -25,076 -22,086
Change in Working Capital 7,471 -1,183 -1,396 7,558
Depreciation Amortization Depletion and Accretion 403 384 -607 358
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 4,375 3,579 4,467 3,488
Total Cash from Operating Activities -20,248 -23,104 -22,612 -10,682
Capital Expenditures -1,951 -900 -940 -2,181
Other Investing Cash Flow 27,551 -22,410 -76,391 14,759
Total Cash from Investing Activities 25,600 -23,310 -77,331 12,578
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 385 1,118 147,042 585
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 0 0 0 0
Total Cash from Financing Activities 385 1,118 147,042 585
Exchange Rate Effects 0 0 0 0
Net Change in Cash 5,737 -45,296 47,099 2,481
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Net Income -80,824 -35,816 -11,120
Change in Working Capital 10,116 -6,470 1,237
Depreciation Amortization Depletion and Accretion 534 115 29
Deferred Taxes 0 0 0
Other Non-Cash Activities 13,560 6,481 77
Total Cash from Operating Activities -56,614 -35,690 -9,777
Capital Expenditures -7,665 -1,708 -56
Other Investing Cash Flow -36,231 -123,521 -40
Total Cash from Investing Activities -43,896 -125,229 -96
Dividends and Distributions 0 0 0
Purchase or Sale of Stock 147,843 235,327 191
Purchase and Retirement of Debt 0 0 0
Other Financing Cash Flow 0 0 0
Total Cash from Financing Activities 147,843 235,327 191
Exchange Rate Effects 0 0 0
Net Change in Cash 47,333 74,408 -9,682